Main > A1. CORP. INDEX. E-Em > Emergent BioSolutions/P C2

---

This data is not available for free

Emergent BioSolutions/P C2's subsections
2006. 06.05.2006. Sanofi Pasteur
2008. 03.06.2008. Anthrax MAb Acq.
2009. 11.13.2009. MdBio Found.
2010. 09.17.2010. Anthrax Vacc. rPA
2012. 03.22.2012. Tuberculosis Vacc
2012. 06.18.2012. BARDA
2012. 11.19.2012. CFO
2012. 12.28.2012. Influenza Vacc.
2013. 04.25.2013. Bracco Diag. Div.
2013. 07.01.2013. Anthrax Vacc
2014. 08.19. Onco.>Prostate C.
2015. 03.25. Inhalational Anthrax
2015. 12.22. Aptevo Therapeutics
2017. 10.03. Inhalational Anthrax
2018. 08.09. Acq. PaxVax
2020. 03.18. COVID-19 Vaxart
2020. 04.02. COVID-19 Plasma-Derive
2023. 03.29. U.S. FDA Approves
Web-Site

Emergent BioSolutions/P C2's products
This section has no products